Central regions | Technology & innovation | Finance, business

Skolkovo and AstraZeneca launch medtech start-up acceleration

16 May '19
Russias Skolkovo Foundation and AstraZeneca, a global biopharmaceutical company, are putting together a new joint acceleration program for projects that develop solutions for cancer therapy, cardiovascular diseases, metabolism and kidney problems, and respiratory diseases, Firrma.ru reported.

Primer Capital, a Russian venture fund with international presence, is acting as partner for the acceleration initiative.

The program will be aimed at identifying promising ideas and solutions to benefit the above-mentioned medical fields and also at addressing a range of specific problems in the existing healthcare system. Developing and promoting digital medicine solutions is also a goal for this years acceleration program.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
17 May '19 | Finance, business | Telecoms, media
16 May '19 | Technology & innovation | Finance, business
14 May '19 | Transport, logistics | Finance, business
13 May '19 | Technology & innovation
 

Feature stories

4 Apr '19
Russian scientists have come up with what they say is...
29 Jan '19
Russian biologists and biophysicists have developed...
2 Nov '18
Drawing upon in-depth interviews, the book channels...
Search (News archive - 21348)
Advertising
Venture_Russia_2018
Advertising
NATT
Advertising
StartUp-Village
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

17 May '19
MTS, one of Russias main mobile operators, has...
16 May '19
The Skolkovo Foundation and AstraZeneca, an...
15 May '19
Last week Moscow-based HeadHunter Group, a leading...

Most read stories from last week